Why Patients Switch to Wegovy: Dosing & Savings Explained
Complete Wegovy Dosing Chart for Switching Patients
Our Wegovy dosing chart provides essential guidance for patients transitioning from other GLP-1 medications like Mounjaro or Ozempic. The standard Wegovy dose escalation follows a structured 20-week protocol: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance (week 17 onwards). This gradual increase helps minimise gastrointestinal side effects while optimising weight management outcomes alongside a reduced-calorie diet and increased physical activity. Your prescriber will determine appropriate starting doses based on your previous GLP-1 experience, ensuring a smooth transition that maintains therapeutic benefits.
Switching between GLP-1 medications requires careful consideration of dose equivalence and individual patient factors. While direct dose conversions aren't standardised, many patients transitioning from Mounjaro find Wegovy's weekly injection schedule and established dosing pathway straightforward to follow. The Wegovy dosing chart eliminates guesswork during your switch, providing clear milestones and expectations. EverydayMeds GPhC #9012878 registered pharmacists work with your prescriber to ensure continuity of care throughout your medication transition.
Wegovy Dosing Chart Pricing: Switch & Save Breakdown
Understanding Wegovy pricing through our dosing chart helps patients make informed switching decisions. Individual pen prices start at £79.99 for 0.25mg starter doses, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for 2.4mg maintenance doses. New customers use code FIRST40 at checkout to access these prices, while returning customers apply code DOSE25. These competitive prices often represent significant savings compared to private clinic consultations or alternative weight management programmes.
Our convenient bundle options complement the Wegovy dosing chart by providing multi-month supplies. The Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks of dose escalation. For patients maintaining steady doses, our Consistency bundles offer two identical pens: Consistency 2.4mg (×2) at £419.99 provides eight weeks of maintenance treatment. The Ultimate Stability Trio delivers three months of 2.4mg maintenance doses for £649.99, ensuring uninterrupted supply during long-term weight management.
Clinical Evidence Supporting Wegovy Dosing Chart Protocols
The Wegovy dosing chart reflects robust clinical evidence from the STEP trial programme. In STEP 1, participants following the standard dose escalation protocol achieved approximately 15% average weight loss at 68 weeks versus 2.4% with placebo, when used alongside diet and exercise modifications. STEP 2 demonstrated around 9.6% weight reduction in patients with type 2 diabetes, while STEP 3 showed approximately clinically studied weight loss with intensive behavioural therapy support.
Long-term data from STEP 5 indicated sustained weight loss of approximately 15.2% at two years, validating the Wegovy dosing chart's maintenance phase approach. The recent SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events (HR 0.80), highlighting benefits beyond weight management. These findings support the structured dose escalation outlined in our Wegovy dosing chart, though individual results may vary based on adherence to dietary and exercise recommendations.
How Wegovy Works Throughout the Dosing Chart Journey
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking natural incretin hormones that regulate appetite and glucose metabolism. As you progress through the Wegovy dosing chart, increasing doses enhance satiety signals to the brain, reducing hunger between meals and promoting feelings of fullness after smaller portions. This mechanism supports sustainable weight management by addressing appetite regulation rather than simply restricting calories. The gradual dose increases outlined in our Wegovy dosing chart allow your body to adapt to these hormonal changes, minimising side effects while optimising therapeutic benefits. Each weekly injection provides consistent medication levels, supporting steady appetite control throughout your weight management journey alongside dietary modifications and increased physical activity.
Ordering Process: From Wegovy Dosing Chart to Delivery
Starting your Wegovy journey using our dosing chart begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (24-hour express service available), ensuring safe prescribing based on MHRA guidelines and your individual circumstances. Once approved, your Wegovy prescription enters our cold-chain delivery system, maintaining the 2-8°C storage requirements essential for medication stability. Next-day delivery ensures you receive your Wegovy doses exactly when needed according to your personalised dosing chart schedule. Our GPhC #9012878 registered pharmacy team coordinates everything from prescription approval to temperature-controlled delivery, making your switch to Wegovy seamless and reliable.
Storage and Practical Guidance for Wegovy Dosing Chart Success
Proper storage ensures your Wegovy doses remain effective throughout the dosing chart progression. Unopened pens require refrigeration at 2-8°C, though they maintain potency for up to 6 weeks at room temperature below 30°C once removed from cold storage. This flexibility makes Wegovy particularly suitable for patients who travel frequently or prefer not to inject cold medication. Each FlexTouch pen delivers precise doses as outlined in your Wegovy dosing chart, with clear dose indicators and simple injection procedures. The pre-filled pen design eliminates dose preparation errors, ensuring you receive exactly the prescribed amount each week. Dose escalation cannot be skipped or accelerated, making adherence to the Wegovy dosing chart timeline essential for optimal tolerability and effectiveness alongside your reduced-calorie diet and exercise programme.
Wegovy Dosing Chart: Tailored Switching Strategies
Patients switching to Wegovy often have unique circumstances that require personalised dosing chart modifications. Those transitioning from daily Ozempic injections appreciate Wegovy's once-weekly convenience, while Mounjaro users may notice different side effect profiles during the switch. Our prescribers consider your previous GLP-1 experience when determining appropriate starting points within the Wegovy dosing chart framework. Some patients may begin at 0.5mg rather than 0.25mg, depending on their tolerance history and current treatment response.
The switching process involves coordinating your final doses of previous medications with Wegovy initiation, ensuring no therapeutic gaps that might affect your weight management progress. EverydayMeds stocks both Wegovy and Mounjaro, allowing seamless pharmacy continuity during your transition period. Your personalised Wegovy dosing chart accounts for individual factors like side effect sensitivity, weight loss goals, and lifestyle preferences, creating a switching strategy that maximises success while minimising disruption to your established routine.
Start Your Wegovy Switch Today: Dosing Chart & Discount Codes
Ready to switch to Wegovy using our comprehensive dosing chart guidance? Visit our weight loss collection to begin your clinical assessment and explore our competitive pricing options. New customers receive their best prices with code FIRST40, while returning patients use DOSE25 at checkout for continued savings. Our prescribers review each application individually, ensuring your Wegovy dosing chart aligns with safe prescribing guidelines and your personal weight management objectives. Remember that Wegovy is a prescription-only medicine requiring ongoing medical supervision alongside dietary and exercise modifications. Contact our clinical team for personalised guidance about switching medications and optimising your weight management strategy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
